Biktarvy, formally known as biktarvy, is a potent single-tablet regimen for treating HIV infection. This formula combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the the viral ability to copy within the body, considerably decreasing the viral quantity. For many individuals, Biktarvy